Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong
· Delayed Price · Currency is HKD 5.37
-0.03 (-0.56%)
At close: Apr 29, 2026
HKG:6922 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 35.03 | 45.46 | 103.4 | 226.42 | 157.87 | Upgrade
|
| Short-Term Investments | 0.67 | 0.81 | 1.05 | 1.92 | 1.43 | Upgrade
|
| Cash & Short-Term Investments | 35.71 | 46.26 | 104.46 | 228.34 | 159.3 | Upgrade
|
| Cash Growth | -22.82% | -55.71% | -54.25% | 43.34% | 379.37% | Upgrade
|
| Receivables | 0.04 | 0.06 | 0.13 | 0.08 | 0.25 | Upgrade
|
| Inventory | 32.88 | 29.87 | 24.35 | 19.93 | 11.7 | Upgrade
|
| Restricted Cash | - | 0 | 0.07 | - | - | Upgrade
|
| Other Current Assets | 22.6 | 21.97 | 20.9 | 15.86 | 18.15 | Upgrade
|
| Total Current Assets | 91.23 | 98.16 | 149.92 | 264.21 | 189.39 | Upgrade
|
| Property, Plant & Equipment | 31.34 | 38.62 | 51.28 | 41.76 | 38.09 | Upgrade
|
| Other Intangible Assets | - | 0 | 0.02 | 0.04 | 0.06 | Upgrade
|
| Other Long-Term Assets | 14.89 | 12.47 | 11.61 | 7.85 | 4.15 | Upgrade
|
| Total Assets | 137.46 | 149.25 | 212.82 | 313.86 | 231.69 | Upgrade
|
| Accounts Payable | 2.49 | 2.41 | 1.15 | 1.87 | 0.38 | Upgrade
|
| Accrued Expenses | 13.16 | 17.05 | 21.68 | 34.77 | 21.07 | Upgrade
|
| Short-Term Debt | 13.13 | 30 | - | - | - | Upgrade
|
| Current Portion of Leases | 9.35 | 5.6 | 3.25 | 3.43 | 2.6 | Upgrade
|
| Current Income Taxes Payable | 3.53 | 1.69 | 2.07 | 1.98 | 1.41 | Upgrade
|
| Current Unearned Revenue | 0.39 | 1.17 | 0.99 | 3.26 | 2.64 | Upgrade
|
| Other Current Liabilities | 18.2 | 1.9 | 1.64 | 0.42 | 0.2 | Upgrade
|
| Total Current Liabilities | 60.24 | 59.82 | 30.78 | 45.73 | 28.29 | Upgrade
|
| Long-Term Leases | 3.72 | 7.72 | 7.76 | 7.94 | 6.41 | Upgrade
|
| Long-Term Unearned Revenue | 8.06 | 2.78 | 0.82 | 0.8 | - | Upgrade
|
| Other Long-Term Liabilities | 16.91 | - | - | - | - | Upgrade
|
| Total Liabilities | 88.92 | 70.32 | 39.36 | 54.47 | 34.7 | Upgrade
|
| Common Stock | 239.11 | 239.11 | 239.11 | 239.11 | 228 | Upgrade
|
| Additional Paid-In Capital | - | 299.77 | 299.77 | 299.77 | 150.64 | Upgrade
|
| Retained Earnings | - | -735.33 | -630.96 | -533.48 | -421.25 | Upgrade
|
| Comprehensive Income & Other | -189.37 | 270.3 | 253.55 | 233.73 | 213.26 | Upgrade
|
| Total Common Equity | 49.74 | 73.85 | 161.47 | 239.13 | 170.65 | Upgrade
|
| Minority Interest | -1.2 | 5.08 | 12 | 20.26 | 26.35 | Upgrade
|
| Shareholders' Equity | 48.53 | 78.93 | 173.46 | 259.39 | 197 | Upgrade
|
| Total Liabilities & Equity | 137.46 | 149.25 | 212.82 | 313.86 | 231.69 | Upgrade
|
| Total Debt | 26.2 | 43.32 | 11.01 | 11.37 | 9 | Upgrade
|
| Net Cash (Debt) | 9.51 | 2.94 | 93.44 | 216.97 | 150.3 | Upgrade
|
| Net Cash Growth | 223.44% | -96.86% | -56.93% | 44.36% | 360.28% | Upgrade
|
| Net Cash Per Share | 0.04 | 0.01 | 0.39 | 0.95 | 0.66 | Upgrade
|
| Filing Date Shares Outstanding | 239.11 | 239.11 | 239.11 | 239.11 | 228 | Upgrade
|
| Total Common Shares Outstanding | 239.11 | 239.11 | 239.11 | 239.11 | 228 | Upgrade
|
| Working Capital | 30.99 | 38.34 | 119.13 | 218.47 | 161.1 | Upgrade
|
| Book Value Per Share | 0.21 | 0.31 | 0.68 | 1.00 | 0.75 | Upgrade
|
| Tangible Book Value | 49.74 | 73.85 | 161.44 | 239.09 | 170.59 | Upgrade
|
| Tangible Book Value Per Share | 0.21 | 0.31 | 0.68 | 1.00 | 0.75 | Upgrade
|
| Buildings | - | 19.24 | 19.24 | - | - | Upgrade
|
| Machinery | - | 22.84 | 18.42 | 34.29 | 29.54 | Upgrade
|
| Construction In Progress | - | 0.49 | 10.15 | 0.8 | 3.27 | Upgrade
|
| Leasehold Improvements | - | 23.75 | 15.58 | 13.8 | 9.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.